![]() HilleVax HilleVax is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. | |||
Founding Date | Founding Date 2020 | Founding Date 2001 | Founding Date 2011 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Boston, US HQ | Locations Illkirch-Graffenstaden, FR HQ Montréal, CA | Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US |
Employees | Employees 31 | Employees 811% decrease | Employees 1561% increase |
Valuation ($) | Valuation ($) 95.1 m | Valuation ($) N/A | Valuation ($) 487.2 m |
Financial | |||
Net income | Net income ($147.3m) (FY, 2024) | Net income N/A | Net income ($115.2m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 41.5m | Total funding raised $ 217.5m |

Domain Therapeutics is a biopharmaceutical company.
View company
AbSci is a company that provides generative AI drug-creation solutions.
View company